Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Daxor Announces Filing of Amended Form 10-K/A for 2005.


NEW YORK New York, state, United States
New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of
 -- The original form 10-K Form 10-K

A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information.


Form 10-K

See 10-K.
 filed by Daxor Corporation (AMEX AMEX

See: American Stock Exchange
:DXR DXR Danbury Municipal Airport, Danbury CT (airport code)
DXR Data Extraction and Recording
DXR X-Director
DXR Dynamic Extended Resolution
), a medical instrumentation and biotechnology company for the year ended December 31, 2005 included restatements and reclassifications for the comparative years ended December 31, 2004 and 2003. Changes in accounting principles and segment reporting which necessitated these restatements and reclassifications were fully disclosed in the original filing.

The original filing only disclosed the net effect of these changes to the financial statements and did not have the level of detailed disclosure required by U.S. generally accepted accounting principles The standard accounting rules, regulations, and procedures used by companies in maintaining their financial records.

Generally accepted accounting principles (GAAP) provide companies and accountants with a consistent set of guidelines that cover both broad accounting
. This Form 10-K for the year ended December 31, 2005 (Form 10-K/A, Amendment No. 1) has been amended to include the required disclosure for the financial statement presentation and accompanying footnotes.

It should be noted that even though the Company has expanded its disclosure of the changes presented in the original Form 10-K filing for the year ended December 31, 2005, the net loss and per share amounts have not changed for any of the years presented.

The company expects to file its form 10-Q for the quarter ended September 30, 2006 on a timely basis.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Nov 10, 2006
Words:188
Previous Article:RingCentral Online Provides Ideal Telecommunications Solution for a Growing Number of Independent Realtors.
Next Article:AAA Foundation Releases Guidelines for Evaluating Effectiveness of Driver Education Programs.
Topics:



Related Articles
Daxor Corporation Announces Third Quarter 2005 Earnings.
Daxor Announces Schnitzler Cardiovascular Consultants of San Antonio Acquires Blood Volume Analyzer BVA-100.
Interest suspension: plus: employment law and partnership agreements.
Daxor Announces St. Luke's Hospital in Bethlehem, PA Acquires Blood Volume Analyzer BVA-100.
Daxor Corporation Announces Year End 2005 Earnings.
Daxor Announces St. Francis Medical Center of Honolulu, HI Acquires Blood Volume Analyzer BVA-100.
Daxor Announces Geisinger Medical Center in Danville, PA Acquires BVA-100 Blood Volume Analyzer.
Daxor Announces Alfieri Cardiology of Newark, DE Acquires Blood Volume Analyzer BVA-100.
Daxor Announces Carolinas Medical Center of Charlotte, NC Purchases BVA-100 and Blood Volume Kit Usage Increases 40%.
Daxor Announces Sacred Heart Hospital in Allentown, PA Acquires Blood Volume Analyzer BVA-100.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles